Revolutionising Medicines Manufacturing Takes Serious Collaboration Feature session - Hosted by CPI

Time & Location

Wednesday: 11.00 to 12.00, Stage 3

Hosted by CPI

Dr. Sam NeillBusiness Development Director - CPI’s Medicines Manufacturing Innovation Centre

About this Session

If partnering has crossed your mind when looking at ways to accelerate your innovation but don’t know where to start, come along to learn how CPI is leveraging the power of partnerships to overcome some of the challenges to successful collaboration.

Through a Grand Challenge model, aimed at tackling the pharmaceutical industry’s largest problems, CPI’s Medicines Manufacturing Innovation Centre is working together with collaborators in a pre-competitive environment, to break down barriers previously limiting the ability and speed of new and innovative technology adoption.

  • Session coordinator: Neil Sheddan, Business Development Director, Medicines Manufacturing Innovation Centre at CPI

Speaker Bio:

CPI Pharma Capabilty Overview:

Sam is a proactive and dynamic business development professional with over 19 years’ experience and is part of the team at CPI’s Medicines Manufacturing Innovation Centre, but also works closely with colleagues in our Biologics and Formulations business units.

Sam’s current role involves working with leading bio and pharmaceutical partners to overcome critical challenges around the large-scale synthesis of oligonucleotides (short stretches of synthetic DNA or RNA) and lipid nanoparticle (LNP) delivery systems that mark a paradigm shift in our ability to effectively treat a wide range of diseases and to protect populations from viruses via the tried and tested ‘Grand Challenge’ model.

Sam holds a PhD in Biological Sciences from the University of Auckland, a BSc (Hons) in Biology from Newcastle University and a BTEC HNC in Business and Finance from Northumbria University.